Brigitta Vcelar

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

Alexandra Trkola, Herbert Kuster, Peter Rusert et al. · Nature Medicine · 2005 · 503 citations

Hiv-1 Rebound, Antiretroviral Therapy, Human Retrovirus +9

Regulatory approval and a first‐in‐human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants

Julian K‐C., Jürgen Drossard, D. J. Lewis et al. · Plant Biotechnology Journal · 2015 · 253 citations · Full text

Engineering, Botany, Genetics +20

Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques

Christiane Moog, N Dereuddre-Bosquet, Jean‐Luc Teillaud et al. · Mucosal Immunology · 2013 · 153 citations · Full text

Immunology, Vaginitis, Vaginal Application +3

Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans

Angela Storka, Brigitta Vcelar, Uros Klickovic et al. · International Journal of Clinical Pharmacology and Therapeutics · 2014 · 136 citations

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer

Richard Greil, Sigrun Greil‐Ressler, Charlotte Schönlieb et al. · Cancer Chemotherapy and Pharmacology · 2018 · 128 citations · Full text